We, therefore, investigate whether Th1‐directed CD4 T‐cell responses to SARS‐CoV‐2 peptides are different in individuals recovered from mild COVID‐19 at 3, 6 and 9 months after recovery within different age groups. The gene discussed is CD4; the disease is COVID-19.